Nanovi, specialized in the development of advanced biomaterials for use in the radiotherapy of cancer, today announced it secured €2.7M from current investors to bring BioXmark® technology to the market. BioXmark™ is a novel injectable liquid tissue marker which improves the accuracy and quality of radiation therapy. It can easily be implemented in today’s routines